What CMS expects for documentation and reporting of leftover anti-VEGF drugs.
The one-year reprieve ends October 1. Here’s what you can expect and how to prepare.
An obvious order and a thorough “interpretation and report” are essential for passing muster in a chart audit.
Changes in 2016 amount to a sharp reduction in physician reimbursements.
A deep dive into how CMS defines and uses Value Based Payment Modifier. Part 2 of 2.
Knowing Medicare’s key measures can help you avoid penalties. Part 1 of 2.
AAO advises restraint with genetic testing; payers go slow.
New guidance from CMS describes why and the few times when you can.